Skip to main content
Equibles

Kevin G. Sarney

CFO

Atara Biotherapeutics, Inc. (ATRA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kevin G. Sarney

Kevin G. Sarney is recorded as CFO at Atara Biotherapeutics, Inc. (ATRA). Atara Biotherapeutics, Inc. reported in an 8-K filed June 26, 2026 that Kevin G. Sarney was appointed interim chief financial officer, effective June 26, 2026.

“On June 26, 2026, the Company’s Board of Directors appointed Kevin G. Sarney, Life Science Practice Leader at Charles River CFO, Inc. (“CRCFO”), as interim chief financial officer, effective as of June 26, 2026.”
Atara Biotherapeutics, Inc. Form 8-K, filed June 26, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Atara Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.